- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03485716
Metabolic Dynamics During Physical Activity
March 30, 2018 updated by: Michael Boschmann, Charite University, Berlin, Germany
Metabolic Dynamics During Physical Activity Under Normobaric Normoxia or Moderate Hypoxia - a Pilot Study
The aim of this study is to systematically Analyse the metabolome in capillary blood of healthy men and women at rest and during defined standardized physical activity under normobaric normoxia or hypoxia with a specific focus on metabolites and metabolic pattern related to energy metabolism.
The metabolome analyses in capillary blood could give us also or more detailed insight into erythrocyte metabolic physiology because it is known for a longer time that the primary metabolism of the erythrocyte reflects its Oxygen Saturation via the glycolytic metabolites / intermediates pattern.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 13125
- Charite University Medicine, ECRC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 51 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy volunteers
- written informed consent
Exclusion Criteria:
- known cardio-vascular, lung, metabolic, endocrine, hematologic, kidney or neurologic diseases
- pregnancy, lactating period
- unability to understand study content and aims and to give written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: running under hypoxia - first
running under hypoxia (first day) and normoxia (second day)
|
|
|
Active Comparator: running under normoxia - first
running under normoxia (first day) and hypoxia (second day)
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in capillary lactate/pyruvate Ratio (dimension-free)
Time Frame: t = 0 min (before exercise); t = 10, 20 and 30 min during exercise; t = 50 and 60 min during recovery
|
marker for the ratio between anaerobic / aerobic glycolysis
|
t = 0 min (before exercise); t = 10, 20 and 30 min during exercise; t = 50 and 60 min during recovery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Michael Boschmann, Dr., Charite University, Berlin, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
March 31, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
March 19, 2018
First Submitted That Met QC Criteria
March 30, 2018
First Posted (Actual)
April 2, 2018
Study Record Updates
Last Update Posted (Actual)
April 2, 2018
Last Update Submitted That Met QC Criteria
March 30, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Hypoxitrain 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Men and Women
-
USDA Beltsville Human Nutrition Research CenterCompleted
-
King's College LondonCompletedHealthy Men and WomenUnited Kingdom
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
Société des Produits Nestlé (SPN)Active, not recruitingHealthy Men and WomenSwitzerland
-
King's College LondonCompleted
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
Metabolic Technologies Inc.CompletedHealthy Men and WomenUnited States
-
King's College LondonCompletedHealthy Men and WomenUnited Kingdom
-
King's College LondonNaturex-DbsCompletedHealthy Men and WomenUnited Kingdom
Clinical Trials on running on a treadmill under normoxia or hypoxia
-
The University of Hong KongThe Hong Kong Polytechnic University; Griffith UniversityCompletedBroad Autism PhenotypeHong Kong
-
Regis UniversityColorado School of MinesUnknownComparing Running-Specific and Traditional Prostheses During Running: Assessing Performance and RiskAmputees | Running With ProsthesisUnited States
-
Joslin Diabetes CenterCompletedHypoglycemia | Physical Activity | Roux-en-Y Gastric Bypass | Post-bariatric HypoglycemiaUnited States
-
Umm Al-Qura UniversityCompletedDiabetic Peripheral NeuropathySaudi Arabia
-
Riphah International UniversityRecruitingBalance AssessmentPakistan
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted